Stay updated with breaking news from Texas Plaintiffs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
For a brief moment in time last April, the U.S. Food and Drug Administration's ("FDA") approval of the commonly-used abortion medication, Mifepristone, was curtailed.
On review, the Fifth Circuit held that Mifepristone could only be prescribed in the first seven weeks of pregnancy, under a physician’s supervision, and the drug cannot be sent by mail, temporarily suspending more recent modifications to the FDA’s approval.
U.S. Food and Drug Administration’s FDA approval of the commonly-used abortion medication, Mifepristone, has been curtailed following federal court decisions in Texas and Washington. DOJ asked the Fifth Circuit to grant an emergency or administrative stay of that decision
Who knew bankruptcy court could be this wild?